These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Glucose and galactose tolerance tests in children with nephrotic syndrome. Blood sugar and level of plasma free fatty acids]. Halikowski B; Kucharska K; Szafran H; Sancewicz-Pach K Ann Pediatr (Paris); 1971; 18(8):563-7. PubMed ID: 5124372 [No Abstract] [Full Text] [Related]
5. [Changes of glycemia, insulinemia (IRI), and non-esterified free fatty acids during dynamic tests in a group of subjects with hepatic cirrhosis. The Rastinon test]. Zandomeneghi R Minerva Med; 1970 Jan; 61(6):185-9. PubMed ID: 5412764 [No Abstract] [Full Text] [Related]
6. [Oral galactose tolerance test for liver function control. Dosage and standards]. Avenarius HJ; Gutjahr L Med Klin; 1971 Dec; 66(50):1734-8. PubMed ID: 5159631 [No Abstract] [Full Text] [Related]
7. Comparison of intravenous and peroral galactose elimination tests with and without ethanol in different clinical conditions. Kesäniemi YA; Kurppa KO; Salaspuro MP Scand J Gastroenterol; 1973; 8(7):593-8. PubMed ID: 4768306 [No Abstract] [Full Text] [Related]
8. [Studies on serum insulin, blood glucose and nonesterified fatty acid following the oral glucose administration to the normal subjects]. Yoshimoto A; Okano N; Maezawa A; Ominato K; Sato T; Koseki Y; Komine S Radioisotopes; 1982 May; 31(5):245-7. PubMed ID: 6753044 [No Abstract] [Full Text] [Related]
9. [On the plasmatic concentration of non-esterified fatty acids during the intravenous tolbutamide test in the aged]. Locatelli GR; Piotti LE G Gerontol; 1966 Oct; 14(10):961-8. PubMed ID: 5993793 [No Abstract] [Full Text] [Related]
10. [Value of various modifications of the oral galactose tolerance test as an indicator of liver function]. Maaz E; Hoffrichter E Z Gesamte Inn Med; 1972 Jul; 27(13):554-9. PubMed ID: 4637839 [No Abstract] [Full Text] [Related]
11. Changes in blood free fatty acid concentration following oral lactose and glucose tolerance tests in infants. Tamir I; Shreyer P; Zurkowski S; Dickerman Z; Werbin B Isr J Med Sci; 1969; 5(6):1128-32. PubMed ID: 5365597 [No Abstract] [Full Text] [Related]
12. [Evaluation of an intravenous galactose tolerance test]. Fukui I; Soyama K; Ono E; Yoshida T; Takino T Rinsho Byori; 1971 Jan; 19(1):14-8. PubMed ID: 5103825 [No Abstract] [Full Text] [Related]
13. [Intravenous galactose tolerance test as liver function test]. Rommel K; Böhmer R; Adam WE Schweiz Med Wochenschr; 1967 Apr; 97(15):484-7. PubMed ID: 5585388 [No Abstract] [Full Text] [Related]
14. Studies in subjects with positive postprandial Clinistix test. 3. Special studies and follow-up of cases with borderline glucose tolerance. Carlström S; Lundquist A; Lundquist I; Nordén A; Scherstén B; Wollmark G Acta Med Scand; 1971 May; 189(5):415-22. PubMed ID: 5578492 [No Abstract] [Full Text] [Related]
15. [The behavior of glucose, pyruvic acid and nonesterified fatty acids following i.v. tolbutamide loading in fatty liver]. Teichmann W; Bchardt U Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):217-20. PubMed ID: 5732400 [No Abstract] [Full Text] [Related]
16. Significance of glucose load in oral glucose tolerance tests. Blood glucose, serum insulin, growth hormone and free fatty acids. Christensen NJ; Orskov H; Hansen AP Acta Med Scand; 1972 Oct; 192(4):337-42. PubMed ID: 5081072 [No Abstract] [Full Text] [Related]
17. [Variations of blood sugar and non-esterified fatty acids after administration of epinephrine and nicotinic acid in subjects with hypothyroidism]. Stoppoloni G; Pierantoni G; De Luca T Pediatria (Napoli); 1968 Mar; 76(1):124-33. PubMed ID: 5738513 [No Abstract] [Full Text] [Related]
18. [Upon the influence of galactose infusions on galactose, glucose, insulin and free fatty acids in blood and plasma, and on the urinary excretion of galactose and glucose in men]. Heuckenkamp PU; Zöllner N Z Gesamte Exp Med Einschl Exp Chir; 1970; 153(2):136-49. PubMed ID: 5473450 [No Abstract] [Full Text] [Related]
19. [Plasma levels of triglycerides, cholesterol, non-esterified fatty acids and uric acid, during oral glucose load, in subjects with type II diabetes and diminished glucose tolerance]. Sinagra D; Botta RM; Lo Curzio E; Cerasola GA Boll Soc Ital Biol Sper; 1982 Aug; 58(15):964-70. PubMed ID: 6751356 [TBL] [Abstract][Full Text] [Related]
20. Abnormal glucose tolerance and non-esterified fatty acids (NEFAs) as predictors of non-alcoholic steatohepatitis (NASH): which Ash that ignites the NASH. Osman MM; Osman KA; Ahmed MH J Clin Gastroenterol; 2007 Jan; 41(1):118-9. PubMed ID: 17198075 [No Abstract] [Full Text] [Related] [Next] [New Search]